Crohn's & Colitis Congress 2022: Improving Moderate Ulcerative Colitis Care Crohn’s & Colitis Foundation Perspectives
-
- Wetenschap
Host: Jennifer Caudle, DO
Guest: Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI
When patients with moderate ulcerative colitis fail first-line therapy, it's important to know what to do next. And speaking with your patients about their risks and preferences is key. Join us as Dr. Alan Moss shares highlights from his presentation at the 2022 Crohn's & Colitis Congress on treatment considerations for patients with moderate ulcerative colitis.
Host: Jennifer Caudle, DO
Guest: Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI
When patients with moderate ulcerative colitis fail first-line therapy, it's important to know what to do next. And speaking with your patients about their risks and preferences is key. Join us as Dr. Alan Moss shares highlights from his presentation at the 2022 Crohn's & Colitis Congress on treatment considerations for patients with moderate ulcerative colitis.